Literature DB >> 14521553

Frequency and clinical role of Staphylococcus aureus overinfection in atopic dermatitis in children.

Giampaolo Ricci1, Annalisa Patrizi, Iria Neri, Barbara Bendandi, Massimo Masi.   

Abstract

The goal of this study was to evaluate the frequency and role of Staphylococcus aureus infection in patients with atopic dermatitis (AD). In 81 children, ages 2 months to 9 years, affected with moderate to severe AD, 308 samples from the cutaneous lesions were obtained and analyzed. S. aureus was isolated in 52 children (64.2%). Five of these were also colonized by Streptococcus pyogenes and one by Candida albicans. In 61 patients, total IgE serum level and specific IgE were tested to evaluate their allergic status: in 43 children a diagnosis of extrinsic AD was made, while 18 were affected by intrinsic AD. A higher presence of the bacterium was observed in allergic (71%) versus nonallergic children (49%). Our data demonstrate the importance of S. aureus in the clinical manifestation of AD and, in particular, its role in worsening the eczematous lesions of the face, neck, and perineum in children less than 1 year of age.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521553     DOI: 10.1046/j.1525-1470.2003.20503.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  9 in total

Review 1.  Wound care with antibacterial honey (Medihoney) in pediatric hematology-oncology.

Authors:  Arne Simon; Kai Sofka; Gertrud Wiszniewsky; Gisela Blaser; Udo Bode; Gudrun Fleischhack
Journal:  Support Care Cancer       Date:  2005-08-02       Impact factor: 3.603

2.  Pulsed-field gel electrophoresis of Staphylococcus aureus isolates from atopic patients revealing presence of similar strains in isolates from children and their parents.

Authors:  Sonja Bonness; Christiane Szekat; Natalija Novak; Gabriele Bierbaum
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

Review 3.  An update on the genetics of atopic dermatitis: scratching the surface in 2009.

Authors:  Kathleen C Barnes
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

Review 4.  African American ancestry contribution to asthma and atopic dermatitis.

Authors:  Michelle Daya; Kathleen C Barnes
Journal:  Ann Allergy Asthma Immunol       Date:  2019-02-15       Impact factor: 6.347

5.  Molecular and immunological characterization of Staphylococcus aureus in pediatric atopic dermatitis: implications for prophylaxis and clinical management.

Authors:  Chiara Pascolini; Jolinda Sinagra; Simone Pecetta; Valentina Bordignon; Alessandra De Santis; Laura Cilli; Viviana Cafiso; Grazia Prignano; Bruno Capitanio; Claudio Passariello; Stefania Stefani; Paola Cordiali-Fei; Fabrizio Ensoli
Journal:  Clin Dev Immunol       Date:  2011-10-27

6.  Age and sex prevalence of infectious dermatoses among primary school children in a rural South-Eastern Nigerian community.

Authors:  Eziyi Iche Kalu; Victoria Wagbatsoma; Ephraim Ogbaini-Emovon; Victor Ugochukwu Nwadike; Chiedozie Kingsley Ojide
Journal:  Pan Afr Med J       Date:  2015-02-27

Review 7.  Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.

Authors:  Lisa A Beck; Michael J Cork; Masayuki Amagai; Anna De Benedetto; Kenji Kabashima; Jennifer D Hamilton; Ana B Rossi
Journal:  JID Innov       Date:  2022-04-26

8.  Prospective, comparative clinical pilot study of cold atmospheric plasma device in the treatment of atopic dermatitis.

Authors:  Young Jae Kim; Dong Jun Lim; Mi Young Lee; Woo Jin Lee; Sung Eun Chang; Chong Hyun Won
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

9.  Potential Immunoinflammatory Role of Staphylococcal Enterotoxin A in Atopic Dermatitis: Immunohistopathological Analysis and in vitro Assay.

Authors:  Hee-Woo Lee; Sung Min Kim; Jung Min Kim; Byung Min Oh; Jun Young Kim; Han Jin Jung; Hyun Jung Lim; Byung Soo Kim; Weon Ju Lee; Seok-Jong Lee; Do Won Kim
Journal:  Ann Dermatol       Date:  2013-05-10       Impact factor: 1.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.